152 related articles for article (PubMed ID: 21733131)
1. UBE3A regulates MC1R expression: a link to hypopigmentation in Angelman syndrome.
Low D; Chen KS
Pigment Cell Melanoma Res; 2011 Oct; 24(5):944-52. PubMed ID: 21733131
[TBL] [Abstract][Full Text] [Related]
2. Genome-wide gene expression profiling of the Angelman syndrome mice with Ube3a mutation.
Low D; Chen KS
Eur J Hum Genet; 2010 Nov; 18(11):1228-35. PubMed ID: 20571502
[TBL] [Abstract][Full Text] [Related]
3. Expression of the Rho-GEF Pbl/ECT2 is regulated by the UBE3A E3 ubiquitin ligase.
Reiter LT; Seagroves TN; Bowers M; Bier E
Hum Mol Genet; 2006 Sep; 15(18):2825-35. PubMed ID: 16905559
[TBL] [Abstract][Full Text] [Related]
4. The Angelman syndrome ubiquitin ligase localizes to the synapse and nucleus, and maternal deficiency results in abnormal dendritic spine morphology.
Dindot SV; Antalffy BA; Bhattacharjee MB; Beaudet AL
Hum Mol Genet; 2008 Jan; 17(1):111-8. PubMed ID: 17940072
[TBL] [Abstract][Full Text] [Related]
5. Loss of Angelman Syndrome Protein E6AP Disrupts a Novel Antagonistic Estrogen-Retinoic Acid Transcriptional Crosstalk in Neurons.
El Hokayem J; Weeber E; Nawaz Z
Mol Neurobiol; 2018 Sep; 55(9):7187-7200. PubMed ID: 29388081
[TBL] [Abstract][Full Text] [Related]
6. The Angelman Syndrome protein Ube3A regulates synapse development by ubiquitinating arc.
Greer PL; Hanayama R; Bloodgood BL; Mardinly AR; Lipton DM; Flavell SW; Kim TK; Griffith EC; Waldon Z; Maehr R; Ploegh HL; Chowdhury S; Worley PF; Steen J; Greenberg ME
Cell; 2010 Mar; 140(5):704-16. PubMed ID: 20211139
[TBL] [Abstract][Full Text] [Related]
7. Towards a therapy for Angelman syndrome by targeting a long non-coding RNA.
Meng L; Ward AJ; Chun S; Bennett CF; Beaudet AL; Rigo F
Nature; 2015 Feb; 518(7539):409-12. PubMed ID: 25470045
[TBL] [Abstract][Full Text] [Related]
8. A novel UBE3A sequence variant identified in eight related individuals with neurodevelopmental delay, results in a phenotype which does not match the clinical criteria of Angelman syndrome.
Geerts-Haages A; Bossuyt SNV; den Besten I; Bruggenwirth H; van der Burgt I; Yntema HG; Punt AM; Brooks A; Elgersma Y; Distel B; Valstar M
Mol Genet Genomic Med; 2020 Nov; 8(11):e1481. PubMed ID: 32889787
[TBL] [Abstract][Full Text] [Related]
9. Beyond Epilepsy and Autism: Disruption of GABRB3 Causes Ocular Hypopigmentation.
Delahanty RJ; Zhang Y; Bichell TJ; Shen W; Verdier K; Macdonald RL; Xu L; Boyd K; Williams J; Kang JQ
Cell Rep; 2016 Dec; 17(12):3115-3124. PubMed ID: 28009282
[TBL] [Abstract][Full Text] [Related]
10. Hypersociability in the Angelman syndrome mouse model.
Stoppel DC; Anderson MP
Exp Neurol; 2017 Jul; 293():137-143. PubMed ID: 28411125
[TBL] [Abstract][Full Text] [Related]
11. Episodic tremors representing cortical myoclonus are characteristic in Angelman syndrome due to UBE3A mutations.
Goto M; Saito Y; Honda R; Saito T; Sugai K; Matsuda Y; Miyatake C; Takeshita E; Ishiyama A; Komaki H; Nakagawa E; Sasaki M; Uto C; Kikuchi K; Motoki T; Saitoh S
Brain Dev; 2015 Feb; 37(2):216-22. PubMed ID: 24796722
[TBL] [Abstract][Full Text] [Related]
12. Towards an understanding of Angelman syndrome in mice studies.
Yang X
J Neurosci Res; 2020 Jun; 98(6):1162-1173. PubMed ID: 31867793
[TBL] [Abstract][Full Text] [Related]
13. The Angelman syndrome protein Ube3a/E6AP is required for Golgi acidification and surface protein sialylation.
Condon KH; Ho J; Robinson CG; Hanus C; Ehlers MD
J Neurosci; 2013 Feb; 33(9):3799-814. PubMed ID: 23447592
[TBL] [Abstract][Full Text] [Related]
14. Delayed loss of UBE3A reduces the expression of Angelman syndrome-associated phenotypes.
Sonzogni M; Hakonen J; Bernabé Kleijn M; Silva-Santos S; Judson MC; Philpot BD; van Woerden GM; Elgersma Y
Mol Autism; 2019; 10():23. PubMed ID: 31143434
[TBL] [Abstract][Full Text] [Related]
15. Detection of a deletion of exons 8-16 of the UBE3A gene in familial Angelman syndrome using a semi-quantitative dosage PCR based assay.
Boyes L; Wallace AJ; Krajewska-Walasek M; Chrzanowska KH; Clayton-Smith J; Ramsden S
Eur J Med Genet; 2006; 49(6):472-80. PubMed ID: 16740422
[TBL] [Abstract][Full Text] [Related]
16. UBE3A regulates the transcription of IRF, an antiviral immunity.
Furumai R; Tamada K; Liu X; Takumi T
Hum Mol Genet; 2019 Jun; 28(12):1947-1958. PubMed ID: 30690483
[TBL] [Abstract][Full Text] [Related]
17. Assessing the requirements of prenatal UBE3A expression for rescue of behavioral phenotypes in a mouse model for Angelman syndrome.
Sonzogni M; Zhai P; Mientjes EJ; van Woerden GM; Elgersma Y
Mol Autism; 2020 Sep; 11(1):70. PubMed ID: 32948244
[TBL] [Abstract][Full Text] [Related]
18. Ubiquitin-protein ligase E3A (UBE3A) mediation of viral infection and human diseases.
Chaudhary P; Proulx J; Park IW
Virus Res; 2023 Oct; 335():199191. PubMed ID: 37541588
[TBL] [Abstract][Full Text] [Related]
19. Enhanced Nociception in Angelman Syndrome Model Mice.
McCoy ES; Taylor-Blake B; Aita M; Simon JM; Philpot BD; Zylka MJ
J Neurosci; 2017 Oct; 37(42):10230-10239. PubMed ID: 28931574
[TBL] [Abstract][Full Text] [Related]
20. Tissue-specific variation of Ube3a protein expression in rodents and in a mouse model of Angelman syndrome.
Gustin RM; Bichell TJ; Bubser M; Daily J; Filonova I; Mrelashvili D; Deutch AY; Colbran RJ; Weeber EJ; Haas KF
Neurobiol Dis; 2010 Sep; 39(3):283-91. PubMed ID: 20423730
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
